Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	74.79B -4.3%
Revenue (ttm)	21.10B +36.0%
Net Income	3.08B -24.4%
EPS	24.04 -22.3%
Shares Out	124.02M
PE Ratio	18.50
Forward PE	15.57
Dividend	11.67 (1.94%)
Ex-Dividend Date	Jun 20, 2025

Volume	1,803,496
Average Volume	1,790,665
Open	602.00
Previous Close	603.00
Day's Range	574.00 - 611.00
52-Week Range	468.42 - 795.00
Beta	0.68
RSI	67.18
Earnings Date	Mar 5, 2026

About TPE:6472

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 36
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.